Changeable proteins cause nerve disease

An incorrectly folded protein is one of the reasons behind the nerve disease ALS, according to new research. But the protein does not have structural errors all the time and only certain types contribute to the harmful protein accumulations that cause the ALS disease.

BMAs: Run your own business

After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project between Swedish public actors and some companies aims to change that and make entrepreneurs of BMAs.

Hey Kurt Berndt...

... who is starting up a research center for youths in Saltsjöbaden.

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

How to get the most out of the fair

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. And according to her, rigorous planning is the way to succeed.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.

Teams up with leading dermatologist

Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.

Athera signs production partnership

The companys novel cardiovascular product will be manufactured in Germany.

Grant for development projects in Gothenburg

Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.

New CEO to Promedvi

Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.

New member to Active board

The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be re-elected at the AGM in May.

Almost 150 will leave Coloplast

The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Researchers goes to the bottom of the brain

Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.

Vitamin D is mental health aid

Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

Harmony prevents dementia

People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Swedish multi competent machine soon launched

The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.